Michael Klichinsky's most recent trade in Carisma Therapeutics Inc was a trade of 56,982 Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Carisma Therapeutics Inc | Michael Klichinsky | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2025 | 56,982 | 0 | - | - | Stock Option (right to buy) | |
| Carisma Therapeutics Inc | Michael Klichinsky | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.25 per share. | 07 Oct 2025 | 56,982 | 0 | - | 0.3 | 14,485 | Common Stock |
| Carisma Therapeutics Inc | Michael Klichinsky | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.11 per share. | 07 Oct 2025 | 56,982 | 56,982 | - | 0.1 | 6,268 | Common Stock |
| Carisma Therapeutics Inc | Michael Klichinsky | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.25 per share. | 01 Oct 2025 | 200,000 | 119,347 | - | 0.3 | 50,860 | Common Stock |
| Carisma Therapeutics Inc | Michael Klichinsky | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.26 per share. | 01 Oct 2025 | 165,000 | 319,347 | - | 0.3 | 42,405 | Common Stock |
| Carisma Therapeutics Inc | Michael Klichinsky | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.26 per share. | 01 Oct 2025 | 119,347 | 0 | - | 0.3 | 31,078 | Common Stock |
| Carisma Therapeutics Inc | Michael Klichinsky | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 221,000 | 221,000 | - | - | Stock Option (Right to Buy) | |
| Carisma Therapeutics Inc | Michael Klichinsky | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Carisma Therapeutics Inc | Klichinsky Michael | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 170,500 | 170,500 | - | - | Stock Option (Right to Buy) | |
| Carisma Therapeutics Inc | Michael Klichinsky | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 238,000 | 238,000 | - | - | Stock Option (Right to Buy) |